Cited by

• Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilization.

  Betschel SD, Warrington RJ, Schellenberg R. Betschel SD, et al. Allergy Asthma Clin Immunol. 2016 Jul 27;12:32. doi: 10.1186/s13223-016-0138-9. eCollection 2016. Allergy Asthma Clin Immunol. 2016. PMID: 27468299 Free PMC article. Review.
• Surveillance study on the tolerability and safety of Flebogamma^® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.

  Alsina L, Mohr A, Montañés M, Oliver X, Martín E, Pons J, Drewe E, Papke J, Günther G, Chee R, Gompels M; investigators of the Flebogamma DIF PASS Study Group. Alsina L, et al. Pharmacol Res Perspect. 2017 Oct;5(5):e00345. doi: 10.1002/prp2.345. Pharmacol Res Perspect. 2017. PMID: 28971614 Free PMC article.
• Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

  Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A. Marchesi A, et al. Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3. Ital J Pediatr. 2018. PMID: 30157897 Free PMC article. Review.
• Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature.

  Harmon M, Riazi K, Callum J, Arnold DM, Barty R, Sidhu D, Heddle NM, MacLeod L, Li N. Harmon M, et al. Allergy Asthma Clin Immunol. 2023 Sep 16;19(1):85. doi: 10.1186/s13223-023-00841-z. Allergy Asthma Clin Immunol. 2023. PMID: 37717038 Free PMC article.
• Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort.

  Yalcin Gungoren E, Yorgun Altunbas M, Dikici U, Meric Z, Eser Simsek I, Kiykim A, Can S, Karabiber E, Yakici N, Orhan F, Cokugras H, Aydogan M, Ozdemir O, Bilgic Eltan S, Baris S, Ozen A, Karakoc-Aydiner E. Yalcin Gungoren E, et al. J Clin Immunol. 2024 Aug 5;44(8):169. doi: 10.1007/s10875-024-01771-0. J Clin Immunol. 2024. PMID: 39098942 Free PMC article.